These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 21404328)
21. BCNU-loaded poly(D, L-lactide-co-glycolide) wafer and antitumor activity against XF-498 human CNS tumor cells in vitro. Seong H; An TK; Khang G; Choi SU; Lee CO; Lee HB Int J Pharm; 2003 Jan; 251(1-2):1-12. PubMed ID: 12527170 [TBL] [Abstract][Full Text] [Related]
22. Nanofibrous poly(lactide-co-glycolide) membranes loaded with diamond nanoparticles as promising substrates for bone tissue engineering. Parizek M; Douglas TE; Novotna K; Kromka A; Brady MA; Renzing A; Voss E; Jarosova M; Palatinus L; Tesarek P; Ryparova P; Lisa V; dos Santos AM; Warnke PH; Bacakova L Int J Nanomedicine; 2012; 7():1931-51. PubMed ID: 22619532 [TBL] [Abstract][Full Text] [Related]
23. Preparation, characterization, and cytotoxicity of CPT/Fe₂O₃-embedded PLGA ultrafine composite fibers: a synergistic approach to develop promising anticancer material. Amna T; Hassan MS; Nam KT; Bing YY; Barakat NA; Khil MS; Kim HY Int J Nanomedicine; 2012; 7():1659-70. PubMed ID: 22615530 [TBL] [Abstract][Full Text] [Related]
24. Poly(lactic-co-glycolic) acid as a carrier for imaging contrast agents. Doiron AL; Homan KA; Emelianov S; Brannon-Peppas L Pharm Res; 2009 Mar; 26(3):674-82. PubMed ID: 19034628 [TBL] [Abstract][Full Text] [Related]
25. Biocompatible and pH-sensitive PLGA encapsulated MnO nanocrystals for molecular and cellular MRI. Bennewitz MF; Lobo TL; Nkansah MK; Ulas G; Brudvig GW; Shapiro EM ACS Nano; 2011 May; 5(5):3438-46. PubMed ID: 21495676 [TBL] [Abstract][Full Text] [Related]
26. In vitro degradation of poly (D, L-lactide-co-glycolide) nanoparticles loaded with linamarin. Hussein AS; Abdullah N; Ahmadun FR IET Nanobiotechnol; 2013 Jun; 7(2):33-41. PubMed ID: 24046903 [TBL] [Abstract][Full Text] [Related]
27. Spatial Organization of Superparamagnetic Iron Oxide Nanoparticles in/on Nano/Microsized Carriers Modulates the Magnetic Resonance Signal. Lee MK; Clay NE; Ko E; Smith CE; Chen L; Cho N; Sung HJ; DiPietro L; Lee J; Kong H Langmuir; 2018 Dec; 34(50):15276-15282. PubMed ID: 30458616 [TBL] [Abstract][Full Text] [Related]
28. Combinatorial co-encapsulation of hydrophobic molecules in poly(lactide-co-glycolide) microparticles. Acharya AP; Lewis JS; Keselowsky BG Biomaterials; 2013 Apr; 34(13):3422-30. PubMed ID: 23375950 [TBL] [Abstract][Full Text] [Related]
29. Investigation of the factors influencing the release rates of cyclosporin A-loaded micro- and nanoparticles prepared by high-pressure homogenizer. Lee WK; Park JY; Yang EH; Suh H; Kim SH; Chung DS; Choi K; Yang CW; Park JS J Control Release; 2002 Dec; 84(3):115-23. PubMed ID: 12468215 [TBL] [Abstract][Full Text] [Related]
30. Stability of proteins encapsulated in injectable and biodegradable poly(lactide-co-glycolide)-glucose millicylinders. Kang J; Lambert O; Ausborn M; Schwendeman SP Int J Pharm; 2008 Jun; 357(1-2):235-43. PubMed ID: 18384984 [TBL] [Abstract][Full Text] [Related]
31. Doxorubicin release from core-shell type nanoparticles of poly(DL-lactide-co-glycolide)-grafted dextran. Jeong YI; Choi KC; Song CE Arch Pharm Res; 2006 Aug; 29(8):712-9. PubMed ID: 16964768 [TBL] [Abstract][Full Text] [Related]
32. Fabrication, characterization and in vitro evaluation of poly(D,L-lactide-co-glycolide) microparticles loaded with polyamidoamine-plasmid DNA dendriplexes for applications in nonviral gene delivery. Intra J; Salem AK J Pharm Sci; 2010 Jan; 99(1):368-84. PubMed ID: 19670295 [TBL] [Abstract][Full Text] [Related]
33. Preparation and in vitro evaluation of doxorubicin-loaded Fe₃O₄ magnetic nanoparticles modified with biocompatible copolymers. Akbarzadeh A; Mikaeili H; Zarghami N; Mohammad R; Barkhordari A; Davaran S Int J Nanomedicine; 2012; 7():511-26. PubMed ID: 22334781 [TBL] [Abstract][Full Text] [Related]
34. Design of physostigmine-loaded polymeric microparticles for pretreatment against exposure to organophosphate agents. Chaw CS; Tan CW; Yang YY; Wang L; Moochhala S Biomaterials; 2003 Mar; 24(7):1271-7. PubMed ID: 12527268 [TBL] [Abstract][Full Text] [Related]
35. PVA bio-nanocomposites: a new take-off using cellulose nanocrystals and PLGA nanoparticles. Rescignano N; Fortunati E; Montesano S; Emiliani C; Kenny JM; Martino S; Armentano I Carbohydr Polym; 2014 Jan; 99():47-58. PubMed ID: 24274478 [TBL] [Abstract][Full Text] [Related]
36. Enhanced encapsulation and bioavailability of breviscapine in PLGA microparticles by nanocrystal and water-soluble polymer template techniques. Wang H; Zhang G; Ma X; Liu Y; Feng J; Park K; Wang W Eur J Pharm Biopharm; 2017 Jun; 115():177-185. PubMed ID: 28263795 [TBL] [Abstract][Full Text] [Related]
37. Poly(lactide-co-glycolide)/hydroxyapatite nanofibrous scaffolds fabricated by electrospinning for bone tissue engineering. Lao L; Wang Y; Zhu Y; Zhang Y; Gao C J Mater Sci Mater Med; 2011 Aug; 22(8):1873-84. PubMed ID: 21681656 [TBL] [Abstract][Full Text] [Related]
39. Physicomechanical properties of biodegradable poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) films in the dry and wet states. Kranz H; Ubrich N; Maincent P; Bodmeier R J Pharm Sci; 2000 Dec; 89(12):1558-66. PubMed ID: 11042603 [TBL] [Abstract][Full Text] [Related]
40. Development of facile drug delivery platform of ranibizumab fabricated PLGA-PEGylated magnetic nanoparticles for age-related macular degeneration therapy. Yan J; Peng X; Cai Y; Cong W J Photochem Photobiol B; 2018 Jun; 183():133-136. PubMed ID: 29704861 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]